Fed Circuit to address cannabis clash

The dispute centres on a process for extracting CBD from cannabis plant material, which anticipates the use of CBD as an anti-epileptic treatment.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

HeartFlow targets AI cardiac imaging rival over patents and trade secrets

27 October 2026 The 179-page lawsuit alleges that a Boston-based company used patented technology and confidential information from former employees to develop a competing cardiac imaging product.

Careers

Womble Bond Dickinson loses trio of partners to US rival

27 October 2026 The departing partners bring expertise across molecular biology, biochemistry, small molecule and peptide drugs, including blockbuster therapies, as well as chemical and mechanical technologies.

In-house counsel

‘Companies that don’t leverage AI will struggle to keep up’: Umicore IP chief

26 October 2026 Umicore’s Sean Alexander has seen the profession change considerably over three decades, but some of its biggest changes may still lie ahead. He tells LSIPR why AI is prompting difficult decisions, what he is no longer willing to pay external counsel for and why Europe is the place to watch.

More features

HeartFlow targets AI cardiac imaging rival over patents and trade secrets

Womble Bond Dickinson loses trio of partners to US rival

‘Companies that don’t leverage AI will struggle to keep up’: Umicore IP chief

Mewburn Ellis hires first CTO to boost investment in AI and digital innovation

10x and Parse set to end sequencing feud after appeals court defeat

Dr Reddy’s eyes appeal stakes as Boehringer hearing ends

Amarin and Hikma call time on six-year skinny label fight

WATCH: Medmix global IP head on building business-focused IP teams

Fed Circuit to address cannabis clash

More on this story

Editor's picks

Editor's picks

More features